bioRxiv Science⌕ Search

Biology subjects

Narumi, V. H.

Publications and source records attributed to Narumi, V. H..

2 recordsLinked to original sources

Deep Learning Identifies BMI-Associated Morphologic Features in Breast Cancer Tissue

Multiple epidemiological studies have established obesity as an adverse factor in breast cancer incidence, progression, and clinical outcomes. However, the biological mechanisms underlying these associations remain incompletely understood. In peritumoral adipose tissue, obesity is associated with chronic inflammation, macrophage recruitment, and broader alterations in the local microenvironment. Whether these obesity-associated changes are accompanied by distinct morphologic features within the tumor and non-adipose stromal compartments remains unclear. In this study, we investigated whether an AI-based pathology foundation model could support the development of machine learning algorithms capable of identifying obesity-associated morphologic patterns in histopathology images, with a particular focus on tumor and stromal regions. In a cohort of 195 patients with breast cancer, machine learning models using vector embeddings from non-adipose stromal regions classified high BMI ([&ge;]30 kg/m2) versus low BMI (<25 kg/m2) with an average AUC of 0.78 (95% CI: 0.73-0.83), consistently outperforming models based on tumor-only or combined tumor-stroma regions. These obesity-associated stromal signatures were observed across subgroups defined by hormone-receptor status and age, indicating that they are not restricted to specific clinical populations. Complementary embedding-based dissimilarity analysis further showed that higher BMI was associated with reduced inter-patient heterogeneity in both tumor and stromal tissues. Overall, these findings suggest that obesity is associated with distinct morphologic alterations in both tumor and non-adipose stromal tissues. Notably, the stromal compartment emerged as a particularly informative indicator of obesity-associated morphology and demonstrated reduced inter-patient heterogeneity among individuals with high BMI.

cancer biology↗

Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2+ breast cancer

Preclinical murine models in which primary tumors spontaneously metastasize to distant organs are valuable tools to study metastatic progression and novel cancer treatment combinations. Here, we characterize a novel syngeneic murine breast tumor cell line, NT2.5-lung metastasis (- LM), that provides a model of spontaneously metastatic neu-expressing breast cancer with quicker onset of widespread metastases after orthotopic mammary implantation in immune-competent NeuN mice. Within one week of orthotopic implantation of NT2.5-LM in NeuN mice, distant metastases can be observed in the lungs. Within four weeks, metastases are also observed in the bones, spleen, colon, and liver. Metastases are rapidly growing, proliferative, and responsive to HER2-directed therapy. We demonstrate altered expression of markers of epithelial-to-mesenchymal transition (EMT) and enrichment in EMT-regulating pathways, suggestive of their enhanced metastatic potential. The new NT2.5-LM model provides more rapid and spontaneous development of widespread metastases. Besides investigating mechanisms of metastatic progression, this new model may be used for the rationalized development of novel therapeutic interventions and assessment of therapeutic responses targeting distant visceral metastases SUMMARY STATEMENTWe characterize a new syngeneic, immune-competent murine model of breast cancer (NT2.5-LM) that yields rapid and widespread metastases, preserves spontaneous metastasis, and provides a model for studying novel therapeutic interventions.

cancer biology↗